{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:47:46Z","timestamp":1792205266051,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10067-024-06950-3","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T10:01:38Z","timestamp":1712224898000},"page":"1647-1656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Divergent perspectives: exploring the relationships between St. George\u2019s Respiratory Questionnaire and outcome measures in systemic sclerosis\u2013associated interstitial lung disease"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-3972","authenticated-orcid":false,"given":"Enes","family":"Basaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-2032","authenticated-orcid":false,"given":"Duygu","family":"Temiz Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-9488","authenticated-orcid":false,"given":"Ozgur","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-493X","authenticated-orcid":false,"given":"Neslihan","family":"Gokcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-4509","authenticated-orcid":false,"given":"Ayten","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-7969","authenticated-orcid":false,"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"10373","key":"6950_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2023) Systemic sclerosis. Lancet 401(10373):304\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(22)01692-0","journal-title":"Lancet"},{"issue":"10","key":"6950_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6950_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248\u20131254. https:\/\/doi.org\/10.1164\/rccm.200706-877OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"6950_CR4","first-page":"783","volume":"48","author":"PL Enright","year":"2003","unstructured":"Enright PL (2003) The six-minute walk test. Respir Care 48(8):783\u2013785","journal-title":"Respir Care"},{"issue":"2 Suppl","key":"6950_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/2397198320904178","volume":"5","author":"LA Saketkoo","year":"2020","unstructured":"Saketkoo LA, Scholand MB, Lammi MR, Russell AM (2020) Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials. J Scleroderma Relat Disord 5(2 Suppl):48\u201360. https:\/\/doi.org\/10.1177\/2397198320904178","journal-title":"J Scleroderma Relat Disord"},{"issue":"26","key":"6950_CR6","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380(26):2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"},{"key":"6950_CR7","doi-asserted-by":"publisher","unstructured":"Jones PW, Quirk FH, Baveystock CM (1991) The St George\u2019s Respiratory Questionnaire. Respir Med 85 (Suppl B):25\u201331. https:\/\/doi.org\/10.1016\/s0954-6111(06)80166-6.\u00a0","DOI":"10.1016\/s0954-6111(06)80166-6"},{"key":"6950_CR8","doi-asserted-by":"publisher","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory Questionnaire. Am Rev Respir Dis 145(6):1321\u20137.\u00a0https:\/\/doi.org\/10.1164\/ajrccm\/145.6.1321","DOI":"10.1164\/ajrccm\/145.6.1321"},{"issue":"1","key":"6950_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12931-019-1169-9","volume":"20","author":"TS Prior","year":"2019","unstructured":"Prior TS, Hoyer N, Shaker SB et al (2019) Validation of the IPF-specific version of St. George\u2019s Respiratory Questionnaire. Respir Res 20(1):199. https:\/\/doi.org\/10.1186\/s12931-019-1169-9","journal-title":"Respir Res"},{"issue":"6","key":"6950_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00408-020-00394-7","volume":"198","author":"KH Lo","year":"2020","unstructured":"Lo KH, Donohue J, Judson MA, Wu Y, Barnathan ES, Baughman RP, Sarcoidosis T-48 Investigators (2020) The St. George\u2019s Respiratory Questionnaire in pulmonary sarcoidosis Lung 198(6):917\u2013924. https:\/\/doi.org\/10.1007\/s00408-020-00394-7","journal-title":"George\u2019s Respiratory Questionnaire in pulmonary sarcoidosis Lung"},{"issue":"5","key":"6950_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-017-3678-5","volume":"37","author":"V StrevensBolmgren","year":"2017","unstructured":"StrevensBolmgren V, Olsson P, Wollmer P, Hesselstrand R, Mandl T (2017) Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 37(5):813\u2013818. https:\/\/doi.org\/10.1007\/s00296-017-3678-5","journal-title":"Rheumatol Int"},{"issue":"9","key":"6950_CR12","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1007\/s10067-021-05693-9","volume":"40","author":"A Topcu","year":"2021","unstructured":"Topcu A, Mursaloglu HH, Yalcinkaya Y et al (2021) Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability. Clin Rheumatol 40(9):3797\u20133805. https:\/\/doi.org\/10.1007\/s10067-021-05693-9","journal-title":"Clin Rheumatol"},{"issue":"9","key":"6950_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ et al (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4(9):708\u2013719. https:\/\/doi.org\/10.1016\/S2213-2600(16)30152-7","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6950_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/nejmoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L et al (2018) Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 378(1):35\u201347. https:\/\/doi.org\/10.1056\/nejmoa1703327","journal-title":"N Engl J Med"},{"issue":"24","key":"6950_CR15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK et al (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311(24):2490\u20132498. https:\/\/doi.org\/10.1001\/jama.2014.6368","journal-title":"JAMA"},{"issue":"7","key":"6950_CR16","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.40114","volume":"69","author":"ER Volkmann","year":"2017","unstructured":"Volkmann ER, Tashkin DP, Li N et al (2017) Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of scleroderma lung studies I and II. Arthritis Rheumatol 69(7):1451\u20131460. https:\/\/doi.org\/10.1002\/art.40114","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"6950_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3899\/jrheum.180441","volume":"46","author":"ER Volkmann","year":"2019","unstructured":"Volkmann ER, Tashkin DP, Sim M et al (2019) Cyclophosphamide for systemic sclerosis-related interstitial lung disease: a comparison of scleroderma lung study I and II. J Rheumatol 46(10):1316\u20131325. https:\/\/doi.org\/10.3899\/jrheum.180441","journal-title":"J Rheumatol"},{"issue":"11","key":"6950_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6950_CR19","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"2","key":"6950_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm","volume":"209","author":"G Raghu","year":"2024","unstructured":"Raghu G, Montesi SB, Silver RM et al (2024) Treatment of systemic sclerosis-associated interstitial lung disease: evidence-based recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 209(2):137\u2013152. https:\/\/doi.org\/10.1164\/rccm","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"6950_CR21","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281\u20131285","journal-title":"J Rheumatol"},{"issue":"38","key":"6950_CR22","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2022) 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"issue":"5","key":"6950_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","volume":"43","author":"M Hudson","year":"2014","unstructured":"Hudson M, Baron M, Tatibouet S et al (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey. Semin Arthritis Rheum 43(5):666\u2013672. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.09.008","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"6950_CR24","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 200(8):e70\u2013e88. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"6950_CR25","doi-asserted-by":"publisher","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test American journal of respiratory and critical care medicine. 66(1):111\u20137. https:\/\/doi.org\/10.1164\/ajrccm.166.1.at1102","DOI":"10.1164\/ajrccm.166.1.at1102"},{"issue":"7","key":"6950_CR26","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10067-019-04494-5","volume":"38","author":"D TemizKaradag","year":"2019","unstructured":"TemizKaradag D, Karakas F, Tekeoglu S, Yazici A, Isik OO, Cefle A (2019) Validation of Turkish version of the Scleroderma Health Assessment Questionnaire. Clin Rheumatol 38(7):1917\u20131923. https:\/\/doi.org\/10.1007\/s10067-019-04494-5","journal-title":"Clin Rheumatol"},{"key":"6950_CR27","doi-asserted-by":"publisher","unstructured":"Polatl\u0131 M, Yorganc\u0131o\u011flu A, Aydemir \u00d6 et al (2013) St. George solunum anketinin T\u00fcrk\u00e7e ge\u00e7erlilik ve g\u00fcvenilirli\u011fi [Validity and reliability of Turkish version of St. George's respiratory questionnaire]. Tuberk Toraks 61(2):81\u20137. https:\/\/doi.org\/10.5578\/tt.5404","DOI":"10.5578\/tt.5404"},{"key":"6950_CR28","unstructured":"Cohen J et al (2002) Applied multiple regression\/correlation analysis for the behavioral sciences. 3rd edn. Routledge, New York"},{"issue":"160","key":"6950_CR29","doi-asserted-by":"publisher","first-page":"210026","DOI":"10.1183\/16000617.0026-2021","volume":"30","author":"M Kalluri","year":"2021","unstructured":"Kalluri M, Luppi F, Vancheri A et al (2021) Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here? Eur Respir Rev 30(160):210026. https:\/\/doi.org\/10.1183\/16000617.0026-2021","journal-title":"Eur Respir Rev"},{"key":"6950_CR30","doi-asserted-by":"publisher","unstructured":"Roofeh D, Barratt SL, Wells AU et al (2021) Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: a systematic review using the OMERACT filter 2.1 process. Semin Arthritis Rheum 51(6):1331\u20131341. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.08.001","DOI":"10.1016\/j.semarthrit.2021.08.001"},{"issue":"5","key":"6950_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","volume":"69","author":"LA Saketkoo","year":"2014","unstructured":"Saketkoo LA, Mittoo S, Huscher D et al (2014) Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax 69(5):428\u2013436. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204202","journal-title":"Thorax"},{"issue":"18","key":"6950_CR32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"issue":"4","key":"6950_CR33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720\u2013735. https:\/\/doi.org\/10.1183\/09031936.05.00034905","journal-title":"Eur Respir J"},{"issue":"4","key":"6950_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1440-1843.2012.02133.x","volume":"17","author":"M Wilsher","year":"2012","unstructured":"Wilsher M, Good N, Hopkins R et al (2012) The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology 17(4):647\u2013652. https:\/\/doi.org\/10.1111\/j.1440-1843.2012.02133.x","journal-title":"Respirology"},{"issue":"Suppl 5","key":"6950_CR35","doi-asserted-by":"publisher","first-page":"v68","DOI":"10.1093\/rheumatology\/ken273","volume":"47","author":"AJ Impens","year":"2008","unstructured":"Impens AJ, Wangkaew S, Seibold JR (2008) The 6-minute walk test in scleroderma\u2013how measuring everything measures nothing. Rheumatology (Oxford) 47(Suppl 5):v68\u2013v69. https:\/\/doi.org\/10.1093\/rheumatology\/ken273","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6950_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13075-017-1489-4","volume":"19","author":"S Sanges","year":"2017","unstructured":"Sanges S, Giovannelli J, Sobanski V et al (2017) Factors associated with the 6-minute walk distance in patients with systemic sclerosis. Arthritis Res Ther 19(1):279. https:\/\/doi.org\/10.1186\/s13075-017-1489-4","journal-title":"Arthritis Res Ther"},{"key":"6950_CR37","doi-asserted-by":"publisher","unstructured":"Kreuter M, Hoffmann-Vold AM, Matucci-Cerinic M et al (2023) Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford) 62(SI):SI43-SI53. https:\/\/doi.org\/10.1093\/rheumatology\/keac325","DOI":"10.1093\/rheumatology\/keac325"},{"issue":"4","key":"6950_CR38","doi-asserted-by":"publisher","first-page":"e003426","DOI":"10.1136\/rmdopen-2023-003426","volume":"9","author":"L Petelytska","year":"2023","unstructured":"Petelytska L, Bonomi F, Cannistr\u00e0 C et al (2023) Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review. RMD Open 9(4):e003426. https:\/\/doi.org\/10.1136\/rmdopen-2023-003426","journal-title":"RMD Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06950-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:16:13Z","timestamp":1713158173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06950-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6950"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06950-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study adhered to the principles of the Declaration of Helsinki and received approval from the Kocaeli University School of Medicine Ethics Committee in Kocaeli, Turkey, with project number KOU\/GOKAEK 2023\/129.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients who participated in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}